HIF-IN-1（Cat No.:I043686）is a small molecule inhibitor that targets hypoxia-inducible factors (HIFs), specifically HIF-1α, a transcription factor involved in cellular responses to low oxygen levels (hypoxia). HIF-1α regulates genes associated with cell survival, angiogenesis, and metabolism during hypoxic conditions, which are commonly found in tumors. By inhibiting HIF-1α, HIF-IN-1 disrupts the adaptation of cancer cells to hypoxia, potentially reducing tumor growth and metastasis. It is being researched for its therapeutic potential in oncology, with a focus on enhancing the effectiveness of cancer treatments by targeting the tumor microenvironment.